(DIR) Return Create A Forum - Home --------------------------------------------------------- MS Speaks (HTM) https://msspeaks.createaforum.com --------------------------------------------------------- ***************************************************** (DIR) Return to: TREATMENTS ***************************************************** #Post#: 4508-------------------------------------------------- (Abst.) Effectiveness of cladribine compared to fingolimod, nata lizumab, ocrelizumab, alemtuzumab... By: agate Date: August 7, 2024, 12:59 am --------------------------------------------------------- From PubMed (August 2, 2024)--"Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab, and alemtuzumab in relapsing-remitting multiple sclerosis": (HTM) https://pubmed.ncbi.nlm.nih.gov/39087208/ *****************************************************